Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 5, 2003, Pages 915-921

  Revel Vilk, S ^a   Chan, A ^a   Bauman, M ^a   Massicotte, P ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Pediatric; Prothrombotic coagulation proteins; Thromboembolism

Indexed keywords

EID: 0347965820     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00158.x     Document Type: Article

References (33)

1. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D. Venous thromboembolic complications (VTE) in children. first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251-7.
2. van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HSA, Peters M. Venous thromboembolism in childhood: a prospective 2-year registry in the Netherlands. J Pediatr 2001; 139: 676-81.
3. Ryan DH, Crowther MA, Ginsberg JS, Francis CW. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med 1998; 128: 270-6.
4. Ehrenforth S, Junker R, Koch HG, Kreuz W, Munchow N, Scharrer I, Nowak-Gö ttl U. Multicenter evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Eur J Pediatr 1999; 158 (Suppl. 3): S97-104.
5. Chalmers EA. Heritable thrombophilia and childhood thrombosis. Blood Rev 2001; 15: 181-9.
6. Pineo GF, Hull RD. Thrombophilia: disorders predisposing to venous thromboembolism. Baillie'res Clin Haematol 1998; 11: 525-40.
7. von Depka M, Nowak-Göttl U, Eisert R, Dieterich C, Barthels M, Scharrer I, Ganser A, Ehrenforth S. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96: 3364-8.
8. Nowak-Göttl U, Junker R, Hartmeier M, Koch HG, Munchow N, Assmann G, von Eckardstein A. Increased lipoprotein (a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100: 743-8.
9. den Heijer M, Keijzer MB. Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med 2001; 39: 710-3.
10. Kraaijenhagen RA, Anker PS, KoopmanMMW, Reitsma PH, Prins MH, van den Ende A, Buller HR. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83: 5-9.
11. Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
12. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95: 3678-82.
13. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2000; 109: 704-15.
14. Andrew M, Monagle PT, Brooker L. Thromboembolic complications during infancy and childhood. Canada: BC Decker, 2000.
15. deVeber G, Monagle P, Chan A, MacGregor D, Curtis R, Lee S, Vegh P, Adams M, Marzinotto V, Leaker M, Massicotte MP, Lillicrap D, Andrew M. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998; 55: 1539-43.
16. Bonduel M, Hepner M, Sciuccati G, Pieroni G, Torres AF, Maradarz C, Frontroth JP. Factor V Leiden and prothrombotic gene G20210A mutation in children with venous thromboembolism. Thromb Haemost 2002; 87: 972-7.
17. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998; 133: 777-81.
18. Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single center. Arch Dis Child 1999; 81: 176-8.
19. Heller C, Becker S, Scharrer I, Kreuz W. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr 1999; 158 (Suppl. 3): S117-21.
20. Kosch A, von Kries R, Nowak-Göttl U. Thrombosen im kindesalter. Monatsschr Kinderheilkd 2000; 148: 387-97.
21. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, Rechavi G, Inbal A. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000; 31: 1283-8.
22. Leebeek FW, Stadhouders NA, van Stein D, Gomez-Garcia EB, Kappers-Klunne MC. Hypercoagulability states in upper-extremity deep venous thrombosis. Am J Hematol 2001; 67: 15-9.
23. Margaglione M, Brancaccio V, Ciampa A, Papa ML, Grandone E, Di Minno G. Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings. Haematologica 2001; 86: 634-9.
24. Kosch A, Junker R, Kurnik K, Schobess R, Gunther G, Koch H, Nowak-Göttl U. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res 2000; 99: 531-7.
25. Nowak-Göttl U, Junker R, KreuzW, von Eckardstein A, Kosch A, Nohe N, Schobess R, Ehrenforth S. Childhood Thrombophilia Study Group: risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97: 858-62.
26. Kearon C, Crowther M, Hirsh J. Management of patients with hereditary hypercoagulable disorders. Annu Rev Med 2000; 51: 169-85.
27. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
28. Rosendaal FR, Doggen CJM, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-8.
29. Dykes AC,Walker ID, McMahon AD, Islam SIAM, Tait RC. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-41.
30. Koster T, Rosendaal FR, Breit E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitema PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia study). Blood 1995; 85: 2756-61.
31. Faioni EM, Valsecchi C, Palla A, Taioli E, Razzari C, Mannucci PM. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost 1997; 78: 1343-6.
32. Walker ID, Greaves M, Preston FE. Investigation and management of heritable thrombophilia. Br J Haematol 2001; 114: 512-28.
33. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.